ADIPOQ and myeloid sarcoma: A higher level of hs-CRP (≥1.00 mg/L), or IL-6 (≥1.50 pg/mL) or a lower level of adiponectin (<7.90 μg/mL) were associated with a significantly greater risk of MS.